Last Wednesday, diabetes researchers and advocates from around the country convened in Washington, DC, for an FDA hearing on the Artificial Pancreas with the aim of making this pipe dream a reality. The point of the hearing was to allow JDRF and other stakeholders — researchers, industry reps, and patients — a chance to provide input on the Artificial Pancreas Project, in particular “recommendations to ensure the safe and effective testing of artificial pancreas technology…Read more »
I hope everyone enjoyed their weekend, and the (for you too?) gorgeous weather that blessed us for World Diabetes Day 2010.
Here in San Francisco, Kelly Close and her team at Close Concerns collaborated with the local JDRF chapter, and ADA too, to bring us a fantastic rally at the Yerba Buena Rooftop Gardens near the SF Convention Center. It was a perfect evening:
You’ll be happy to know that we surpassed our goal for…Read more »
Are you ready, PWDs? I hope you have your calendar marked for this Sunday, Nov. 14: World Diabetes Day 2010.
What to do to help the cause? There are plenty of campaigns to get behind this month, but here are my Top 4 suggestions:
* Find out what’s happening in your city/ state / town and be part of it this Sunday!
To do this, you can:
Browse the International Diabetes Federation’s calendar of 300+…Read more »
In memory of those who have lost their battle with diabetes…
For a long a time, many of us in the Diabetes Community have been wishing there were a place to honor Loved Ones and Friends who’ve been taken away by this disease. I personally have been toying with the idea for several years, but somehow never got around to making it happen.
Luckily, I recently ran into Barbra Marche of the Canadian-based site DiabetesAdvocacy,…
Why is affordable generic insulin not available to patients in the US? Mainly because the big manufacturers have a stronghold on the patents for this complicated “biologic” drug. But now it seems Big Pharma itself may be presenting a nice alternative.
What I’m talking about is Pfizer’s new attempt to enter the injectable insulin market (less risky than their Exubera flop!) Pfizer and Biocon, a biopharmaceutical company in India, recently announced a multimillion dollar partnership…